BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Staging
96 results:

  • 1. High-Throughput Metabolic Pattern Screening Strategy for Early Colorectal and gastric cancers Based on Covalent Organic Frameworks-Assisted Laser Desorption/Ionization Mass Spectrometry.
    Yang C; Yu H; Li W; Lin H; Wu H; Deng C
    Anal Chem; 2024 Apr; 96(16):6264-6274. PubMed ID: 38600676
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Online tools to predict individualised survival for primary oesophageal cancer patients with and without pathological complete response after neoadjuvant therapy followed by oesophagectomy: development and external validation of two independent nomograms.
    Cao Y; Huang B; Tang H; Dong D; Shen T; Chen X; Feng X; Zhang J; Shi L; Li C; Jiao H; Tan L; Zhang J; Li H; Zhang Y
    BMJ Open Gastroenterol; 2024 Mar; 11(1):. PubMed ID: 38538088
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Perioperative or neoadjuvant chemotherapy for locally advanced gastric or gastroesophageal junction cancer: from independent evidence in the West, the East, and Japan to global collaboration.
    Nakayama I; Ohashi M; Nunobe S
    Chin Clin Oncol; 2024 Feb; 13(1):8. PubMed ID: 38453658
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. High Expression of THY1 in Intestinal gastric cancer as a Key Factor in Tumor Biology: A Poor Prognosis-Independent Marker Related to the Epithelial-Mesenchymal Transition Profile.
    Rohan P; Dos Santos EC; Abdelhay E; Binato R
    Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38254918
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A nomogram incorporating treatment data for predicting overall survival in gastroenteropancreatic neuroendocrine tumors: a population-based cohort study.
    Wu Z; Shang G; Zhang K; Wang W; Fan M; Lin R
    Int J Surg; 2024 Apr; 110(4):2178-2186. PubMed ID: 38241384
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Development and validation of a preoperative CT-based risk scoring system for predicting recurrence-free survival in patients undergoing curative surgery for gastric cancer.
    Zhu Z; Gong H; Gu J; Dai Y; Yang C; Mao M; Song A; Feng F
    Eur J Radiol; 2024 Feb; 171():111303. PubMed ID: 38215532
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Operative Link on Gastritis Assessment (OLGA) system as a marker for gastric cancer and dysplasia in a Colombian population at risk: A multicenter study.
    Carlosama YH; Acosta CP; Sierra CH; Rosero CY; Bolaños HJ
    Biomedica; 2023 Dec; 43(Sp. 3):30-40. PubMed ID: 38207154
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A preoperative predictive tool to assess the need for staging laparoscopy in oesophagogastric cancer patients.
    Halle-Smith JM; Bage T; Kamarajah SK; Siddaiah-Subramanya M; Pande R; Whiting JL; Griffiths EA
    Ann R Coll Surg Engl; 2024 Apr; 106(4):369-376. PubMed ID: 37642164
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Construction and testing of a risk prediction classifier for cardia carcinoma.
    Liu Z; Xia G; Liang X; Li S; Gong Y; Li B; Deng J
    Carcinogenesis; 2023 Dec; 44(8-9):662-670. PubMed ID: 37624090
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Novel nomogram to predict the overall survival of postoperative patients with gastric signet.
    Liu D; Ding R; Wang L; Shi E; Li X; Zhang C; Zhang Y; Wang X
    BMC Gastroenterol; 2023 Aug; 23(1):284. PubMed ID: 37587418
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Raf kinase inhibitor protein combined with phosphorylated extracellular signal-regulated kinase offers valuable prognosis in gastrointestinal stromal tumor.
    Qu WZ; Wang L; Chen JJ; Wang Y
    World J Gastroenterol; 2023 Jul; 29(26):4200-4213. PubMed ID: 37475847
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. TRIP 13-dependent pathways promote the development of gastric cancer.
    Ni F; Liu X; Xia Y; Zhu H; Li F; Zhang N; Xu H
    Funct Integr Genomics; 2023 Jul; 23(3):232. PubMed ID: 37432513
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Development and validation of a novel nomogram for postoperative overall survival of patients with primary gastric signet-ring cell carcinoma: a population study based on SEER database.
    Nie D; Zheng H; An G; Li J
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8593-8603. PubMed ID: 37097391
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Molecular characteristics, oncogenic roles, and relevant immune and pharmacogenomic features of NEK2 in gastric cancer.
    Wu Z; Zheng J; Zhang H; Shen N; Luo X; Shen C; Song P; Zhang Y; Zhang M; Yang S; Guo G; Xue X; Zhang F; Feng S
    Int Immunopharmacol; 2023 Mar; 116():109737. PubMed ID: 36738674
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Patterns of staging, treatment, and mortality in gastric, colorectal, and lung cancer among older adults with and without preexisting dementia: a Japanese multicentre cohort study.
    Morishima T; Kuwabara Y; Saito MK; Odani S; Kudo H; Kato M; Nakata K; Miyashiro I
    BMC Cancer; 2023 Jan; 23(1):67. PubMed ID: 36658524
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A 9‑gene expression signature to predict stage development in resectable stomach adenocarcinoma.
    Liu Z; Liu H; Wang Y; Li Z
    BMC Gastroenterol; 2022 Oct; 22(1):435. PubMed ID: 36241983
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Phosphoglycerate mutase 1 that is essential for glycolysis may act as a novel metabolic target for predicating poor prognosis for patients with gastric cancer.
    Wei C; Xie J; Yuan X; Luo Y; Xiao Y; Liao W; Jiang Z
    J Clin Lab Anal; 2022 Nov; 36(11):e24718. PubMed ID: 36181311
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Implementation of cinematic rendering of gastric masses into clinical practice: a pictorial review.
    Brookmeyer C; Rowe SP; Chu LC; Fishman EK
    Abdom Radiol (NY); 2022 Oct; 47(10):3386-3393. PubMed ID: 35819482
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Identification of a seven-cell cycle signature predicting overall survival for gastric cancer.
    Zhang LQ; Zhou SL; Li JK; Chen PN; Zhao XK; Wang LD; Li XL; Zhou FY
    Aging (Albany NY); 2022 May; 14(9):3989-3999. PubMed ID: 35537781
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A Nomogram Model for Evaluating the Risk of Lymph Node Metastasis in cT2-cT4N0M0 gastric cancer Population.
    Zhang Z; Liu Y; Ma G; Su J
    Med Sci Monit; 2022 May; 28():e935696. PubMed ID: 35527384
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.